This is consistent with other evidence (Schmucker 2001) and suggests that multiple factors such as less blood flow to the liver, smaller liver mass, and decreased specific content of CYPs may combine in elderly individuals to decrease hepatic clearance of drugs.
The liver plays a key role in clearing LPS from the circulation, so increased plasma LPS may reflect decreased hepatic clearance [ 85, 87, 88].
Use of an antiepileptic drug may require a lower dose of propofol, because some types of antiepileptics are known to decrease hepatic metabolism [ 8].
They also decrease hepatic glucose production by improving hepatic insulin sensitivity.
However, impaired hepatic uptake would also be expected to decrease hepatic exposure and biliary excretion.
Alternatively, as suggested, cirrhotic patients may simply exhibit decreased hepatic clearance of this protein [ 22].
These drugs may decrease the expression of hepatic sterol transporters indirectly, via miR-33.
Retention and accumulation of hydrophobic bile salts (that is, tauro- and glicochenodeoxycholate) may decrease antioxidant activities of hepatic catalase, glutathione peroxidase, reduced glutathione (GSH) and superoxide dismutase levels and induce hepatocyte necrosis by activating mitochondrial membrane permeability transition [ 63- 67].
NAC treatment during the first hours of sepsis or septic shock may decrease peroxidative stress [40], improve hepatic function [34], and enhance tissue oxygenation and cardiac function [41], whereas delayed administration adversely affected the outcomes of critically ill patients with multiple organ failure [33, 42].
Our results show that LSTS on Qimen (LR14) may decrease MPO activates to reduce hepatic I/R injury.
